News
02-09-2010, 04:09 AM
In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK. When activated, RSK is involved in cell survival, cell proliferation and cell enlargement...
More... (http://mnt.to/f/3xmX)
More... (http://mnt.to/f/3xmX)